Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide.

As shown in Figure 2(d ), mice treated with AXT201 showed a decreasing trend in tumor volume with a significant 41% reduction ( p < .05) on day 38, the last day all mice were alive ( Figure 2(e) ).

also in 47,180 other papers